Attenuation of diastolic heart failure and life-threatening ventricular tachyarrhythmia after peripheral blood stem cell transplantation combined with cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis

Circulation Journal

Volumn 72, Issue 2, 2008, Pages 331-334

  Yaoita, Hiroyuki ^a   Iwai Takano, Masumi ^a   Ogawa, Kazuei ^a   Suzuki, Hitoshi ^a   Akutsu, Kazuko ^a   Noji, Hideyoshi ^a   Kamiyama, Yoshiyuki ^a   Kimura, Satoshi ^a   Ohtake, Hideki ^a   Ishibashi, Toshiyuki ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Amyloid; Arrhythmia; Cardiomyopathy; Heart failure; Transplantation

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; DEXAMETHASONE; DIURETIC AGENT; MELPHALAN; TECHNETIUM 99M;

AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; DEFIBRILLATOR; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GRAFT REJECTION; HEART AMYLOIDOSIS; HEART CATHETERIZATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART MUSCLE PERFUSION; HEART VENTRICLE TACHYCARDIA; HUMAN; MULTIPLE MYELOMA; PATIENT REFERRAL; QUANTITATIVE DIAGNOSIS; RESUSCITATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNCOPE; TREATMENT OUTCOME;

AGED; AMYLOIDOSIS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TACHYCARDIA; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 40949098679     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.331     Document Type: Article

References (17)

1. Cueto-Garcia L, Tajik AJ, Kyle RA, Edwards WD, Greipp PR, Callahan JA, et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: An introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 1984; 59: 589-597.
2. Nakamura M, Satoh M, Kowada S, Satoh H, Tashiro A, Sato F, et al. Reversible restrictive cardiomyopathy due to light-chain deposition disease. Mayo Clin Proc 2002; 77: 193-196.
3. Dispenzieri A, Kyle RA, Lacy MQ, Therneau TM, Larson DR, Plevak MF, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study. Blood 2004; 103: 3960-3963.
4. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004; 104: 1881-1887.
5. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 2004; 140: 85-93.
6. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003; 41: 1797-1804.
7. Klein AL, Hatle LK Taliercio CP, Taylor CL, Kyle RA, Bailey KR, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990; 16: 1135-1141.
8. Samad BA, Olson JM, Alam M. Characteristics of left ventricular diastolic function in patients with systolic heart failure: A Doppler tissue imaging study. J Am Soc Echocardiogr 2005; 18: 896-900.
9. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367.
10. Rajkumar SV, Kyle RA. Multiple myeloma: Diagnosis and treatment. Mayo Clin Proc 2005; 80: 1371-1382.
11. Wright BL, Grace AA, Goodman HJ. Implantation of a cardioverter- defibrillator in a patient with cardiac amyloidosis. Nat Clin Pract Cardiovasc Med 2006; 3: 110-114.
12. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, et al, MADIT II. The Multicenter Automatic Defibrillator Implantation Trial: Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005; 69: 19-22.
13. Richter S, Duray G, Gronefeld G, W Israel C, H Hohnloser S. Prevention of sudden cardiac death: lessons from recent controlled trials. Circ J 2005; 69: 625-629.
14. Tsuneyoshi H, Nishina T, Nemoto T, Kanemitsu H, Kawakami R, Unimonh O, et al. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation 2004; 110(Suppl 1): II-174-II-179.
15. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004; 94: 1008-1010.
16. Itoh M, Ohmori K, Yata K, Wada H, Tsuchiya T, Okahashi N, et al. Implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis. Am J Hematol 2006; 81: 560-561.
17. Parikh S, de Lemos JA. Current therapeutic strategies in cardiac amyloidosis. Curr Treat Options Cardiovasc Med 2005; 7: 443-448.